|
Real-time Estimate
Cboe BZX
22:40:52 22/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.365 USD | -4.25% |
|
+5.53% | +46.32% |
| 10-06 | Guggenheim Initiates Ovid Therapeutics at Buy | MT |
| 09-21 | Ovid Therapeutics Inc.(NasdaqCM:OVID) added to S&P Global BMI Index | CI |
Company Valuation: Ovid Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 218.6 | 131.1 | 227.6 | 66.3 | 212.2 | 482.4 | - | - |
| Change | - | -40.04% | 73.64% | -70.87% | 220.05% | 127.33% | - | - |
| Enterprise Value (EV) 1 | 218.6 | 131.1 | 227.6 | 66.3 | 212.2 | 355.4 | 151.2 | -58.71 |
| Change | - | -40.04% | 73.64% | -70.87% | 220.05% | 67.48% | -57.46% | -138.84% |
| P/E | 1.82x | -2.42x | -4.35x | -2.52x | -7.09x | -6.85x | -6.41x | -6.21x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 1.12x | 0.1x | 0.2x | -0.1x | -0.94x | -1.93x |
| Capitalization / Revenue | 1.05x | 87.2x | 581x | 117x | 29.3x | 609x | 1,481x | 45.1x |
| EV / Revenue | 1.05x | 87.2x | 581x | 117x | 29.3x | 449x | 464x | -5.49x |
| EV / EBITDA | 1.76x | -2.38x | -3.95x | -1.1x | - | -5.02x | -1.74x | 0.45x |
| EV / EBIT | 1.47x | -2.36x | -3.84x | -1.07x | -5x | -4.93x | -1.71x | 0.57x |
| EV / FCF | - | - | - | - | -5.54x | -5.04x | -1.84x | 0.55x |
| FCF Yield | - | - | - | - | -18.1% | -19.8% | -54.4% | 182% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.76 | -0.77 | -0.74 | -0.37 | -0.23 | -0.3608 | -0.3854 | -0.3978 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 208.4 | 1.503 | 0.3917 | 0.566 | 7.252 | 0.7916 | 0.3256 | 10.69 |
| EBITDA 1 | 124.4 | -55.04 | -57.68 | -60.18 | - | -70.8 | -86.7 | -130.4 |
| EBIT 1 | 149.2 | -55.55 | -59.28 | -61.88 | -42.44 | -72.02 | -88.49 | -103.7 |
| Net income 1 | 122.8 | -54.17 | -52.34 | -26.43 | -17.41 | -66.32 | -83.13 | -96.94 |
| Net Debt 1 | - | - | - | - | - | -127 | -331.2 | -541.1 |
| Reference price 2 | 3.210 | 1.860 | 3.220 | 0.934 | 1.630 | 2.470 | 2.470 | 2.470 |
| Nbr of stocks (in thousands) | 68,092 | 70,467 | 70,681 | 71,010 | 130,184 | 195,298 | - | - |
| Announcement Date | 15/03/22 | 13/03/23 | 08/03/24 | 11/03/25 | 18/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.85x | 448.93x | -5.02x | - | 482M | |
| 19.17x | 6.81x | 13.53x | 1.55% | 66.22B | |
| 30.52x | 8.19x | 25.9x | 0.05% | 55.2B | |
| 36.31x | 6.45x | 19.27x | 0.89% | 52.79B | |
| 35.25x | 3.42x | 14.76x | -.--% | 45.53B | |
| 50.87x | 5.89x | 32.33x | -.--% | 43.94B | |
| -20.15x | 197.1x | -21.43x | -.--% | 41.64B | |
| 29.51x | 8.36x | 21.63x | 0.36% | 34B | |
| 29.85x | 6.32x | 16.4x | -.--% | 25.84B | |
| 32.16x | 5.92x | 19.93x | -.--% | 23.51B | |
| Average | 23.67x | 69.74x | 13.73x | 0.32% | 38.92B | |
| Weighted average by Cap. | 26.72x | 27.42x | 15.85x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- OVID Stock
- Valuation Ovid Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
